TCTMD looks at the TRIUMPH-2 and SYNCHRONIZE-2 results in people with diabetes, where both new drugs worked well but left some open questions.
Recap by typeshit. Full story at TCTMD.
A professor walks through peptides as short amino acid chains and their roles in cell signaling and regulation.
A Mayo Clinic Florida study of over 3,800 women found 9.8% vs 8.2% weight loss at 9 months with HT on semaglutide. Researchers say it shows association, not cause.
Stanford doctors look at what peptides are and whether the online wellness hype holds up, covering possible upsides alongside the risks.
His GLP-1 series turns to heart failure with preserved ejection fraction, where the heart pumps normally but struggles to relax and fill.
Gizmodo reports recent company data pointing to measurable slowing of biological aging markers in people on GLP-1 drugs.
A patient prescribed a GLP-1 says the pharmacy quoted a little over $500, likely per month, and asks others how they handled a coverage denial.
Loading…